All tenders
75N94026F00001
THE CONTRACTOR SHALL COORDINATE, MAINTAIN AND MANAGE NICHD PARTICIPATING SITES FOR IMPAACT 2050 / CREATE - PHASE IV STUDY OF THE PHARMACOKINETICS OF LONG-ACTING INJECTABLE CABOTEGRAVIR AND RILPIVIRINE IN PREGNANT AND POSTPARTUM WOMEN WITH HIV IN THE
Department of Health and Human Services · MD, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N94026F00001
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- THE CONTRACTOR SHALL COORDINATE, MAINTAIN AND MANAGE NICHD PARTICIPATING SITES FOR IMPAACT 2050 / CREATE - PHASE IV STUDY OF THE PHARMACOKINETICS OF LONG-ACTING INJECTABLE CABOTEGRAVIR AND RILPIVIRINE IN PREGNANT AND POSTPARTUM WOMEN WITH HIV IN THE
- Source
- usaspending
- Source ID
- CONT_AWD_75N94026F00001_7529_75N94023D00001_7529
Details
- Location
- MD, United States
Description
THE CONTRACTOR SHALL COORDINATE, MAINTAIN AND MANAGE NICHD PARTICIPATING SITES FOR IMPAACT 2050 / CREATE - PHASE IV STUDY OF THE PHARMACOKINETICS OF LONG-ACTING INJECTABLE CABOTEGRAVIR AND RILPIVIRINE IN PREGNANT AND POSTPARTUM WOMEN WITH HIV IN THE Awarded to: WESTAT, INC. Sub-agency: National Institutes of Health Contract type: DELIVERY ORDER
Dates
- Publication
- 2026/09/28 12:00:00 AM UTC
- Closing date
- 2031/09/27 12:00:00 AM UTC
Estimated value
$2.5M USD
Classification
Normalized category
Healthcare & Medical